These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 2994986)

  • 41. Enalapril in treatment of hypertension with renal artery stenosis. Changes in blood pressure, renin, angiotensin I and II, renal function, and body composition.
    Hodsman GP; Brown JJ; Cumming AM; Davies DL; East BW; Lever AF; Morton JJ; Murray GD; Robertson JI
    Am J Med; 1984 Aug; 77(2A):52-60. PubMed ID: 6089557
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A randomized, controlled, multicenter study to compare prazosin GITS with enalapril in hypertensive patients with diabetes mellitus. Bombay Hypertension Study Group.
    Joglekar SJ; Nanivadekar AS
    J Assoc Physicians India; 1998; Suppl 1():52-62. PubMed ID: 11233387
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of angiotensin-converting enzyme inhibition on plasma aldosterone concentration, plasma renin activity, and blood pressure in spontaneously hypertensive cats with chronic renal disease.
    Steele JL; Henik RA; Stepien RL
    Vet Ther; 2002; 3(2):157-66. PubMed ID: 19750747
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
    Luque Otero M; Martell Claros N;
    Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lisinopril versus lisinopril plus hydrochlorothiazide in essential hypertension.
    Mehta J; Lopez LM; Thorman AD
    Am J Cardiol; 1988 Apr; 61(10):803-6. PubMed ID: 2833090
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term enalapril--a new converting enzyme inhibitor--in the treatment of mild to moderate essential hypertension, results of a worldwide multiclinic study. Comparing two ways of analyzing data.
    Lessem JN; Rucinska E; Vickers FF; Espie J; Sromovsky JA
    Clin Exp Hypertens A; 1985; 7(11):1515-39. PubMed ID: 3002672
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Renal and endocrine effects of long-term converting enzyme inhibition as compared with calcium antagonism in essential hypertension.
    Katzman PL; Henningsen NC; Fagher B; Thulin T; Hulthén UL
    J Cardiovasc Pharmacol; 1990 Mar; 15(3):360-4. PubMed ID: 1691357
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of the efficacy and safety of enalapril plus hydrochlorothiazide plus methyldopa vs standard triple therapy in the treatment of moderate to severe hypertension: results from a multicentre study.
    Leonetti G; Cuspidi C; Sampieri L; Ambrosioni E; Malini PL; Pessina A; Semplicini A; Cinotti G; Morabito S; Rappelli A
    J Hum Hypertens; 1990 Feb; 4(1):5-11. PubMed ID: 2189027
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of lercanidipine plus hydrochlorothiazide vs. lercanidipine plus enalapril on micro and macrocirculation in patients with mild essential hypertension.
    De Ciuceis C; Salvetti M; Paini A; Rossini C; Muiesan ML; Duse S; Caletti S; Coschignano MA; Semeraro F; Trapletti V; Bertacchini F; Brami V; Petelca A; Agabiti Rosei E; Rizzoni D; Agabiti Rosei C
    Intern Emerg Med; 2017 Oct; 12(7):963-974. PubMed ID: 28647890
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Potentiation of the antihypertensive effect of enalapril by randomized addition of different doses of hydrochlorothiazide.
    Dahlöf B; Andrén L; Eggertsen R; Jern S; Svensson A; Hansson L
    J Hypertens Suppl; 1985 Dec; 3(3):S483-6. PubMed ID: 2856773
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative effectiveness of antihypertensive drugs prescribed in Ethiopian healthcare practice: A pilot prospective, randomized, open label study.
    Mengesha HG; Welegerima AH; Hadgu A; Temesgen H; Otieno MG; Tsegay K; Fisseha T; Getachew S; Merha Z; Tewodros H; Dabessa J; Gebreegzabher B; Petrucka P
    PLoS One; 2018; 13(9):e0203166. PubMed ID: 30204768
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enalapril, hydrochlorothiazide, and combination therapy in patients with moderate hypertension.
    Frishman WH; Goldberger J; Sherman D
    J Clin Hypertens; 1987 Dec; 3(4):520-7. PubMed ID: 2839628
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of the antihypertensive effects of delapril and enalapril.
    Rahn KH
    Am J Hypertens; 1991 Jan; 4(1 Pt 2):38S-41S. PubMed ID: 2009146
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A comparative pilot study of enalapril, a new converting enzyme inhibitor, and hydrochlorothiazide in essential hypertension.
    Ferguson RK; Vlasses PH; Irvin JD; Swanson BN; Lee RB
    J Clin Pharmacol; 1982 Jul; 22(7):281-9. PubMed ID: 6286734
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Norepinephrine-induced blood pressure rise and renal vasoconstriction are not attenuated by enalapril treatment in microalbuminuric IDDM.
    Hoogenberg K; Navis G; Dullaart RP
    Nephrol Dial Transplant; 1998 Mar; 13(3):640-5. PubMed ID: 9550640
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Renal protective effect of long term antihypertensive therapy with enalapril.
    Bauer JH; Reams GP
    Drugs; 1988; 35 Suppl 5():62-71. PubMed ID: 2850905
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy and safety of delapril plus manidipine compared with enalapril plus hydrochlorothiazide in mild to moderate essential hypertension: results of a randomized trial.
    Mugellini A; Dobovisek J; Planinc D; Cremonesi G; Fogari R
    Clin Ther; 2004 Sep; 26(9):1419-26. PubMed ID: 15531004
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of antihypertensive therapy on left ventricular function and myocardial perfusion at rest and during exercise.
    Rosendorff C; Goodman C; Coull A
    J Hypertens Suppl; 1984 Dec; 2(2):S63-8. PubMed ID: 6100879
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Changes in the pathophysiologic profile of blood pressure determinants during short-term enalapril administration.
    de Leeuw PW; Birkenhäger WH
    J Cardiovasc Pharmacol; 1986; 8 Suppl 1():S26-9. PubMed ID: 2422490
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of the renin-angiotensin system in hypertension in the elderly.
    Nagano M; Higaki J; Mikami H; Ogihara T
    Blood Press Suppl; 1994; 5():130-3. PubMed ID: 7889195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.